Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
End price
14.12.24
-
Summary
This prediction is currently being closed. Massive losses of -37.75% have been the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kiora Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Kiora Pharmaceuticals Inc.
Buy beendet

